doxepin has been researched along with Cardiotoxicity in 1 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, H | 1 |
Kang, H | 1 |
An, JR | 1 |
Seo, MS | 1 |
Jung, WK | 1 |
Lee, DS | 1 |
Choi, G | 1 |
Yim, MJ | 1 |
Lee, JM | 1 |
Bae, YM | 1 |
Son, YK | 1 |
Choi, IW | 1 |
Park, WS | 1 |
1 other study available for doxepin and Cardiotoxicity
Article | Year |
---|---|
Inhibitory Effect of Tricyclic Antidepressant Doxepin on Voltage-Dependent K
Topics: Animals; Antidepressive Agents, Tricyclic; Cardiotoxicity; Coronary Vessels; Doxepin; Membrane Poten | 2019 |